A QUALITY-ADJUSTED SURVIVAL ANALYSIS IN ADULT AND ELDERLY PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: COMPARING REDUCED-INTENSITY AND FULL-DOSE CHEMOTHERAPY REGIMENS
EHA Library, Fausto Alfredo Rios-Olais, 4161448
LABORATORY EVALUATION, CLINICAL FEATURES, AND PROGNOSTIC ANALYSIS OF ACUTE LEUKEMIA WITH TAF15::ZNF384 FUSION GENE
EHA Library, Zheng Wang, 4161447
FIRST-LINE (1L) AND SECOND-LINE (2L) TREATMENT PATTERNS IN PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN DIFFERENT TIME PERIODS
EHA Library, Nikesh Shah, 4161446
OUTCOMES WITH PRETRANSPLANT BLINATUMOMAB FOLLOWED BY ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION WITH PTCY FOR B CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Noah Merin, 4161445
THE INCIDENCE OF OBESITY AND METABOLIC SYNDROME DEVELOPMENT IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA AFTER COMPLETING TREATMENT
EHA Library, Adalet Meral Güneş, 4161444
EFFICACY IN CLEARING NGS-MRDAND SHORT-TERM PROGNOSIS OF 14-DAY VERSUS 28-DAY BLINATUMOMAB IN PEDIATRIC B-ALL
EHA Library, YingJin Zhang, 4161443
EFFICACY AND SAFETY OF INOTUZUMAB OZOGAMICIN IN ADULT CHINESE PATIENTS WITH RELAPSED OR REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA: PRIMARY RESULTS OF AN OPEN-LABEL, MULTI-CENTER PHASE 4 TRIAL.
EHA Library, Depei Wu, 4161441
18F-FDG PET/CT REVEALED A HIGHER INCIDENCE OF EXTRAMEDULLARY DISEASES IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Ruifeng Hou, 4161440
IMPACT OF ADDITIONAL CHROMOSOME 9 ABNORMALITIES ON OUTCOMES IN BCR::ABL1 POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA - A 10-YEAR NATIONWIDE REGISTRY STUDY
EHA Library, Wasithep Limvorapitak, 4161439
PROSPECTIVE ASSESSMENT OF BONE MINERAL DENSITY, BONE AND MINERAL MARKERS AND BODY COMPOSITION TRENDLINES FOLLOWING ACUTE LYMPHOBLASTIC LEUKAEMIA IN PAEDIATRICS
EHA Library, Adriana Balduzzi, 4161438
EFFICACY AND SAFETY OF BLINATUMOMAB IN NEWLY-DIAGNOSED PATIENTS WITH PH-POSITIVE/NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Yinqiang Zhang, 4161437
THE RETROSPECTIVE, MULTICENTER COHORT STUDY OF CHIDAMIDE MAINTENANCE THERAPY WITH ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA PATIENTS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Xu Chen, 4161436
EFFICACY AND SAFETY OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CD19 CAR-T IN ADULTS WITH HIGH-RISK B-ALL: A PHASE II STUDY
EHA Library, Rongli Zhang, 4161435
EFFICACY AND SAFETY OF THE THIRD-GENERATION TKI OLVEREMBATINIB IN RELAPSED AND PERSISTENT MRD POSITIVE PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
EHA Library, Xinwen Jiang, 4161434
TYROSINE KINASE INHIBITORS WITH BLINATUMOMAB VERSUS CHEMOTHERAPY IN PHILADELPHIA-POSITIVE ACUTE B-LYMPHOBLASTIC LEUKEMIA
EHA Library, Max Rieger, 4161433
INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN PEDIATRIC AND ADOLESCENT PATIENTS
EHA Library, Zuofei Chi, 4161432
SAFETY AND EFFICACY OF CHIDAMIDE AS MAINTENANCE THERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH T-ALL/T-LBL
EHA Library, Kuangfei Wang, 4161431
HAPLOIDENTICAL STEM CELLS TRANSPLANTATION IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS: A MULTICENTER, REAL-WORLD STUDY
EHA Library, Danya Shen, 4161430
ANALYSIS OF RISK FACTORS FOR SECONDARY PANCREATITIS FOLLOWING ASPARAGINASE RE-EXPOSURE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Xuedong Wu, 4161429
UTILITY OF MEASURABLE RESIDUAL DISEASE MONITORING DETECTED BY NGS USING IGH ASSAY AFTER FIRST AND SECOND CYCLE OF CHEMOTHERAPY IN ADULT B-LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A MULTICENTER STUDY.
EHA Library, Chantana Polprasert, 4161428
A GENOMIC PROFILE OF RESISTANT AND RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS: A SINGLE CENTER ANALYSIS.
EHA Library, Anna Płotka, 4161427
EFFICACY OF 8 GRAY FLU-TBI BASED CONDITIONING IN ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE-LYMPHOBLASTIC LEUKEMIA.
EHA Library, Rohan Halder, 4161426
EXPERIENCE WITH BLINATUMOMAB IN PATIENTS WITH PH-NEGATIVE ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA WHO SHOW MINIMAL RESIDUAL DISEASE AT THE END OF INDUCTION THERAPY AS PART OF TREATMENT UNDER THE ALL-2016M PROTOCOL. A SINGLE CENTER EXPERIENCE.
EHA Library, Ekaterina Kotova, 4161425
LOW FIXED DOSE INOTUZUMAB IS EQUALLY EFFECTIVE SINGLE AGENT SALVAGE THERAPY IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Isha Gambhir, 4161424
MUTATIONAL ANALYSIS OF SOMATIC IKAROS MUTATION IN ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Rim Frikha, 4161423
TRANSCRIPTOME DATA ANALYSIS OF 80 B ALL PATIENTS IN CHINA
EHA Library, Yuehui Lin, 4161422
TIME AND DOSE-DEPENDENT EFFECTS OF PERK INHIBITION IN A DUX4-R B- ACUTE LEUKEMIA CELL LINE
EHA Library, Mercilena Benjamin, 4161421
DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Olena Zotova, 4161420
EPIDEMIOLOGICAL PROFILE OF ACUTE LEUKEMIA IN PEDIATRIC PATIENTS: SUBTYPES AND ABERRANT MARKERS IN 111 CASES FROM A HEMATOLOGY DEPARTMENT IN NORTHERN TUNISIA
EHA Library, Roua Hsasna, 4161419
DRUG TRANSPORTER SIGNATURE IN CHILDHOOD ACUTE LEUKEMIA USING AN INTEGRATED APPROACH OF CELL SORTING AND MOLECULAR BIOLOGY: PRELIMINARY FINDINGS.
EHA Library, Alessandra Cianflone, 4161418
COMBINING CYTOMORPHOLOGY AND FLUORESCENCE IN SITU HYBRIDIZATION TO DIAGNOSE NEW SUBTYPES OF PHILADELPHIA CHROMOSOME-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Dongge gao, 4161417
THE ROLE OF TRANSFORMING GROWTH FACTOR BETA 1 AND PLATELETS IN THE DEVELOPMENT OF RESISTANCE OF ACUTE LEUKEMIA TO TREATMENT
EHA Library, Vira Barilka, 4161416
SYNERGISTIC EFFECTS OF OLVEREMBATINIB (HQP1351) COMBINED WITH BCL-2 INHIBITOR LISAFTOCLAX (APG-2575) AND BCL-2/BCL-XL INHIBITOR PELCITOCLAX (APG-1252) IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (T-ALL)
EHA Library, Bo Peng, 4161415
PDGFA AND PDGFB DEFICIENCY IMPAIRS ACUTE LEUKEMIA PATIENTS' SERUM CAPABILITY TO SUSTAIN MULTIPOTENT MESENCHYMAL STROMAL CELLS
EHA Library, Nataliya Petinati, 4161414
IMMUNOPHENOTYPIC AND GENETIC CORRELATIONS IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A REAL-WORLD SETTING
EHA Library, Ana Paula de Azambuja, 4161413
NICLOSAMIDE SYNERGIZES WITH EPIRUBICIN TO OVERCOME DRUG RESISTANCE IN T-ALL CELLS
EHA Library, Fang-Liang Huang, 4161412
AN EXTENDED FLOW CYTOMETRY PANEL AS A SCREENING TOOL FOR PH-LIKE ALL
EHA Library, Adrianna Cieloch, 4161411
TARGETING THE CK2/IKAROS AXIS SENSITIZES IMATINIB ANTI-LEUKEMIA EFFICACY BY REPRESSING GLUT1 EXPRESSION AND GLYCOLYSIS IN PH+ ALL
EHA Library, Linyao Zhang, 4161410
IGJ IMMUNOSTAIN: A USEFUL TOOL FOR SCREENING OF PH POSITIVE AND PH-LIKE B-LYMPHOBLASTIC LEUKEMIA
EHA Library, Chaimae El Mahdaoui, 4161409
A NOVEL SKP2 INHIBITOR TRIGGERS PYROPTOSIS IN PH+ ALL VIA DYSREGULATION OF GLYCEROPHOSPHOLIPID METABOLISM
EHA Library, Jinyi Liu, 4161408
THE CIRCULATING BLOOD PROTEOME OF CHILDHOOD ACUTE LEUKEMIA
EHA Library, Maria Globisch, 4161407
DYNAMIC GLYCOGEN METABOLISM IN ALL RECURRENCE: INTEGRATED CLINICAL-MOLECULAR INSIGHTS FROM A RETROSPECTIVE-PROSPECTIVE COHORT STUDY
EHA Library, Wenqiu Huang, 4161406
MITOCHONDRIAL REGULATION IS DISTURBED IN THE BONE MARROW DERIVED MULTIPOTENT MESENCHYMAL STROMAL CELLS OF PATIENTS WITH ACUTE LEUKEMIA.
EHA Library, Aleksandra Sadovskaya, 4161405
THE SYNERGY OF HDACI CHIDAMIDE WITH CX-4945 ON THERAPEUTIC EFFICACY BY REPRESSING TCL1A TRANSCRIPTION IN HIGH-RISK B-ALL
EHA Library, huimin xiang, 4161404
FLT3 ALTERATIONS ARE FREQUENT IN ADULT PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND CORRELATE WITH HIGH EXPRESSION AND SPECIFIC GENETIC SUBSETS
EHA Library, Rossana Maffei, 4161403
EVALUATION OF CONSISTENCY IN GENE MUTATION DETECTION BY DNA AND RNA IN PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
EHA Library, Gang Xu, 4161401
CIRCULATING TUMOUR DNA ANALYSIS IN FOLLICULAR LYMPHOMA TREATED WITH FIRST-LINE VENETOCLAX, LENALIDOMIDE AND OBINUTUZUMAB ON THE LEVERAGE TRIAL
EHA Library, Piers Blombery, 4159421
Individualized treatment in early relapse for patients with relapsed/refractory multiple myeloma (MM)
EHA Library, Menarini Stemline, 4144097
Managing a Rare Disease: Focus on Paroxysmal Nocturnal Haemoglobinuria (PNH) and Biosimilars
EHA Library, Amgen, 4144096
Paving the Future of Relapsed/Refractory Multiple Myeloma Treatment with Bispecific Antibodies
EHA Library, Regeneron, 4144095
Outcomes and experience: Keeping the patient at the centre of the haemoglobinopathy treatment journey
EHA Library, Vertex Pharmaceuticals, 4144094
Individual journeys: Optimising treatment approaches in chronic lymphocytic leukaemia (CLL)
EHA Library, Johnson & Johnson, 4144093
How I treat rare leukemias: implications of recent advances in blastic plasmacytoid dendritic cell neoplasm (BPDCN)
EHA Library, Menarini Stemline, 4144092
Untangling Complex Rare Hematologic Disorders: Paroxysmal Nocturnal Hemoglobinuria (PNH) and Light Chain Amyloidosis (AL)
EHA Library, Alexion AstraZeneca Rare Disease, 4144091
An interactive journey through treatment selection in relapsed/refractory multiple myeloma (RRMM)
EHA Library, Johnson & Johnson, 4144090
Unravelling the mystery of treatment selection in newly-diagnosed multiple myeloma (NDMM)
EHA Library, Johnson & Johnson, 4144089
PREVIOUS-TRANSPLANT OR NEW-MATCH DONOR CD5 CAR T CELLS IN PEDIATRIC AND ADULT RELAPSED/REFRACTORY T-ALL: FIRST-IN-HUMAN, PHASE 1 STUDY
EHA Library, Jing Pan, 422443
WHOLE-GENOME AND -TRANSCRIPTOME SEQUENCING AS A COMPREHENSIVE PRECISION DIAGNOSTIC TEST IN ACUTE MYELOID LEUKEMIA – A REPORT FROM THE NATIONAL INITIATIVE GENOMIC MEDICINE SWEDEN
EHA Library, Anna Staffas, 422442
A NOVEL SINGLE-CELL MEASURABLE RESIDUAL DISEASE (SCMRD) ASSAY FOR SIMULTANEOUS DNA MUTATION AND SURFACE IMMUNOPHENOTYPE PROFILING
EHA Library, Gema Fuerte, 422441
ULTRASENSITIVE BIOSENSOR FOR NONINVASIVE DIAGNOSIS OF T-LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
EHA Library, Ting Wang, 422440
EPITOPE BASE EDITING IN HAEMATOPOIETIC CELLS OVERCOMES THE OFF-TARGET EFFECTS OF T-ALL BITARGETED IMMUNOTHERAPY
EHA Library, Guoling Wang, 422439
THE COST-EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS SECOND-LINE THERAPY IN PATIENTS WITH LARGE B-CELL LYMPHOMA IN SWEDEN
EHA Library, Viktor Hedlof Kanje, 422438
ZANUBRUTINIB VS. ACALABRUTINIB IN B-CELL MALIGNANCIES: AN ADVERSE EVENT-BASED ECONOMIC ANALYSIS
EHA Library, Talha Munir, 422437
MACHINE LEARNING TO TRANSFORM IRON DEFICIENCY SCREENING: FROM RUSTY TOOLS TO CUTTING-EDGE SOLUTIONS
EHA Library, Daniel Kreuter, 422436
ATTITUDES TO PARTICIPATING IN CLINICAL TRIALS VARY BETWEEN DISTINCT GROUPS OF PEOPLE WITH SICKLE CELL DISEASE: GLOBAL FINDINGS FROM THE LISTEN SURVEY
EHA Library, John James, 422435
ACCESS TO SPECIALIZED PALLIATIVE CARE AND HEALTH CARE UTILISATION IN THE LAST MONTH OF LIFE – THE STOCKHOLM EXPERIENCE
EHA Library, Lena von Bahr, 422434
DEVELOPMENT AND IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM EARLY WARNING INFORMATION SYSTEM FOR HOSPITALIZED PATIENTS WITH HEMATOLOGICAL MALIGNANT TUMOR
EHA Library, Liu Tingting, 422433
FIBRINOLYSIS AND FIBRIN STRUCTURE IN VIVO AND EX VIVO: INSIGHTS INTO NEUTROPHIL EXTRACELLULAR TRAPS
EHA Library, Nikolett Wohner, 422432
COMPARATIVE SAFETY AND EFFECTIVENESS OF APIXABAN VS WARFARIN AND RIVAROXABAN VS WARFARIN IN PATIENTS WITH VENOUS THROMBOEMBOLISM IN FINLAND, NORWAY AND SWEDEN
EHA Library, Waleed Ghanima, 422431
SUPERIOR SELECTIVITY OF CS585 TO THE PROSTACYCLIN RECEPTOR TRANSLATES TO A NEW VIABLE TARGET FOR PREVENTION OF THROMBOSIS
EHA Library, Livia Stanger, 422430
LOW-MOLECULAR-WEIGHT HEPARIN DOES NOT PREVENT VENOUS THROMBOEMBOLISM IN ADULTS WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA; PROSPECTIVE SIDE-STUDY OF THE HOVON-100 TRIAL
EHA Library, Mandy Lauw, 422429
MOLECULAR PROFILING FOR HEREDITARY HEMORRHAGIC TELANGIECTASIA: INSIGHTS FROM A VENERABLE DIAGNOSTIC CENTER
EHA Library, Catarina Silva Pinto, 422428
CHARACTERIZATION OF THE INTERACTION OF BLOOD COAGULATION FACTOR VIII AND THE LIVER SINUSOIDAL ENDOTHELIAL CELL RECEPTOR STABILIN-2
EHA Library, Michela Leoni, 422427
THE ROLE OF IMMUNOSUPPRESSIVE THERAPY FOR INHIBITORS ERADICATION IN POSTPARTUM ACQUIRED HEMOPHILIA A. ARE STEROIDS ALONE ENOUGH? A REAL-LIFE RETROSPECTIVE EXPERIENCE.
EHA Library, Gabriele Sapuppo, 422426
AUTOLOGOUS GENE-CORRECTED STEM CELL-DERIVED HEPATIC ORGANOIDS FOR THE TREATMENT OF FVII DEFICIENCY.
EHA Library, Maria Eugenia Chollet, 422425
SUSTAINED EFFICACY OF MARSTACIMAB IN ADULTS AND ADOLESCENTS WITH SEVERE HEMOPHILIA A OR B WITHOUT INHIBITORS
EHA Library, Shamsah Kazani, 422424
3D MODELS OF MEGAKARYOPOIESIS FOR ADVANCED DIAGNOSIS AND DRUG TESTING IN INHERITED PLATELET DISORDERS
EHA Library, Christian Di Buduo, 422423
A PHASE 3, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH CHRONIC IMMUNE THROMBOCYTOPENIA (AVA-PED-301)
EHA Library, Rachael F. Grace, 422422
ZANUBRUTINIB AND ELTROMBOPAG AS SECOND-LINE TREATMENTS FOR PATIENTS WITH IMMUNE THROMBOCYTOPENIA: AN OPEN-LABEL, RANDOMIZED, CONTROLLED, PHASE 2 TRIAL
EHA Library, Chencong Wang, 422421
EFFICACY AND SAFETY OF THE SYK INHIBITOR SOVLEPLENIB (HMPL-523) IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA IN CHINA (ESLIM-01): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY
EHA Library, Renchi Yang, 422420
CLONAL HEMATOPOIESIS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: AN INTERNATIONAL MULTICENTER STUDY
EHA Library, Bruno Fattizzo, 422419
HOW TO UNTANGLE THE EFFECT OF RED BLOOD CELL TRANSFUSIONS FROM PREOPERATIVE ANEMIA ON POSTOPERATIVE OUTCOME. USE OF MEDIATION ANALYSIS AS STATISTICAL TOOL.
EHA Library, Cynthia So-Osman, 422418
PROTEOSTASIS DYSFUNCTION IS A HALLMARK OF RED CELL SENESCENCE
EHA Library, Sandy Peltier, 422417
UPFRONT ADMINISTRATION OF LOW TITER GROUP O WHOLE BLOOD TO SEVERELY INJURED PATIENTS ADMITTED TO A SHOCK TRAUMA ROOM IS BENEFICIAL AND COULD BE SAFELY APPLIED AT LEVEL 1 TRAUMA CENTERS
EHA Library, Eldad Dann, 422416
ULTRA-MASSIVE TRANSFUSION IS NOT FUTILE: RESULTS FROM THE AUSTRALIAN AND NEW ZEALAND MASSIVE TRANSFUSION REGISTRY (ANZ-MTR)
EHA Library, Marsali Maclean, 422415
SEQUENTIAL INTERVENTIONAL PREDICTION OF MAJOR BLEEDING UNDER DIFFERENT PLATELET TRANSFUSION STRATEGIES IN PRETERM NEONATES.
EHA Library, Hilde van der Staaij, 422414
LOW RATE OF INFECTIOUS MORTALITY OMITTING FLUOROQUINOLONE PROPHYLAXIS IN HIGH-RISK HEMATOLOGICAL PATIENTS, A SINGLE CENTER EXPERIENCE.
EHA Library, ADELE SANTONI, 422413
NGS-BASED PATHOGEN DETECTION IN FEBRILE ALLOGENEIC STEM CELL TRANSPLANT PATIENTS – A PROSPECTIVE SINGLE-CENTRE STUDY
EHA Library, Sophie Weil, 422412
ANAKINRA TO REDUCE FEVER DURING NEUTROPENIA IN AUTOLOGOUS STEM CELL TRANSPLANTATION RECIPIENTS WITH MUCOSITIS: FIRST REPORT OF THE AFFECT-2 STUDY.
EHA Library, Eva Molendijk, 422411
PROCALCITONIN IS SUPERIOR TO FEVER-GUIDED EARLY DISCONTINUATION OF EMPIRICAL ANTIBIOTICS IN HEMATOLOGY PATIENTS WITH FEBRILE NEUTROPENIA OF UNKNOWN ORIGIN
EHA Library, Nick De Jonge, 422410
DYNAMIC STIMULATION PROMOTES FUNCTIONAL TISSUE-LIKE ORGANISATION OF A 3D HUMAN LYMPHOID MICROENVIRONMENT MODEL AND ALLOWS TO STUDY CLL CELLS TRAFFICKING IN VITRO
EHA Library, Dafne Barozzi, 420713
EVALUATION OF GONADAL FUNCTION IN YOUNG MEN AND WOMEN DIAGNOSED WITH HODGKIN LYMPHOMA
EHA Library, Angeliki Georgopoulou, 419172
SINGLE CELL MULTIOMICS IDENTIFIES ABERRANT COMMUNICATION BETWEEN DENDRITIC CELLS AND LEUKAEMIA STEM CELLS AS A THERAPEUTICALLY TARGETABLE AXIS IN JUVENILE MYELOMONOCYTIC LEUKAEMIA
EHA Library, Eleni Louka, 419094
ADVANCING EARLY DETECTION AND IMPROVED TARGETED THERAPY IN MYELOPROLIFERATIVE NEOPLASMS: INSIGHTS FROM MULTIMODAL IMAGING AND NANOPARTICLE-MEDIATED DRUG DELIVERY
EHA Library, Julian Baumeister, 419093
TAGRAXOFUSP EXHIBITS ANTITUMORAL ACTIVITY IN PRECLINICAL MODELS OF MYELOFIBROSIS AND ENHANCES ANTILEUKEMIC ACTIVITY OF JAK INHIBITORS
EHA Library, Vittoria Nicolis di Robilant, 419092
UMBILICAL CORD MESENCHYMAL STROMAL CELLS AMELIORATE MYELOFIBROSIS IN VIVO.
EHA Library, Chien-Chin Lin, 419091
THE ATYPICAL CHEMOKINE RECEPTOR CCRL2 IS UPREGULATED AND PROMOTES INTERFERON-GAMMA SIGNALING IN ADVANCED MYELOPROLIFERATIVE NEOPLASMS.
EHA Library, Theodora Chatzilygeroudi, 419090
EFFICACY OF INCA033989 IN CHRONIC AND ADVANCED FORMS OF CALRDEL52 AND CALRINS5 MYELOPROLIFERATIVE NEOPLASMS (MPN) MODELS
EHA Library, Isabelle Plo, 419089
THE EFFECT OF METHYLATION ON THE LET-7-BCL-XL-BCL2 AXIS AND THE POTENTIAL USE OF BH3 MIMETIC DRUGS IN HISTIOCYTIC NEOPLASMS
EHA Library, Oshrat Hershkovitz-Rokah, 419088
TARGETING EXHAUSTED CYTOTOXIC T CELLS BY CTLA-4 BLOCKADE PROMOTES ELIMINATION OF NEOPLASTIC CELLS IN HUMAN MYELOFIBROSIS XENOGRAFTS
EHA Library, Lara Tavernari, 419087

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings